Phase II study of nanoliposomal irinotecan (nal-IRI) with 5-fluorouracil (5-FU)/folinic acid (FA) in refractory advanced high-grade neuroendocrine cancer (HG-NEC) of gastroenteropancreatic (GEP) or unknown origin.
Document Type
Article
Publication Date
2-4-2020
Publication Title
Journal of clinical oncology
Volume
38(4 Suppl)
Recommended Citation
Gupta, Medhavi; Choi, Minsig; Ramirez, Robert A.; Attwood, Kristopher; Mukherjee, Sarbajit; and Iyer, Renuka V., "Phase II study of nanoliposomal irinotecan (nal-IRI) with 5-fluorouracil (5-FU)/folinic acid (FA) in refractory advanced high-grade neuroendocrine cancer (HG-NEC) of gastroenteropancreatic (GEP) or unknown origin." (2020). School of Medicine Faculty Publications. 1790.
https://digitalscholar.lsuhsc.edu/som_facpubs/1790
COinS